Expansion Opportunity Recent expansion to 12,000 sq ft facilities at Granta Park Cambridge, doubling lab space, plus ongoing recruitment. This indicates increased demand and capacity for more ion channel screening, electrophysiology work, and translational cardiac safety studies, suggesting potential upsell of expanded CRO services and automation-enabled assays to new and existing clients.

Europe Growth New Senior Business Development leadership for Europe and recent hires signal a strategic push into the European market. This presents opportunities to target European pharma and biotech companies seeking specialized ion channel screening, high-throughput assays, and collaboration-friendly CRO partnerships.

Integrated Safety Offer Metrion combines ion channel screening with translational cardiac safety and neuroscience assays using primary neurons. This integrated capability is attractive for partners needing end-to-end preclinical data packages, enabling cross-sell of comprehensive safety and efficacy studies to existing clients and new prospects.

Recognized Campaign Awards for Campaign of the Year at Life Science Sales and Marketing awards suggest strong marketing effectiveness and brand credibility. Leverage awarded reputation in outreach to bolster proposals, invitations to collaborative workshops, and bid opportunities with larger CROs or pharma companies seeking trusted partners.

Academic Outreach Continuation of ion channel focused workshops aimed at PhD students and early career researchers demonstrates commitment to thought leadership and pipeline education. This offers a door to early-stage projects, feeder collaborations, and partnerships with academic spin-outs or biotech startups needing pilot screening and advisory capabilities.